# Taking a GLP-1 Like Ozempic? These Health Risks Are Higher in the Heat
People taking GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro face elevated health risks during hot weather. The medications alter how the body regulates temperature and fluid balance, creating specific vulnerabilities in summer months.
GLP-1 drugs work by slowing gastric emptying and reducing appetite. This mechanism also decreases sweating and impairs the body's natural cooling response. Heat stress becomes harder to manage when sweating diminishes. Additionally, these medications can cause dehydration by reducing fluid intake and increasing sodium loss through the kidneys.
Heat-related illness risk climbs substantially for GLP-1 users. Heat exhaustion and heat stroke occur when body temperature rises to dangerous levels. Symptoms include dizziness, weakness, nausea, and confusion. Heat stroke represents a medical emergency requiring immediate cooling and hospitalization.
Dehydration compounds these risks. GLP-1 medications reduce thirst signals, meaning people drink less even when their bodies need fluids. Combined with reduced sweating, this creates a dangerous cycle. Blood volume drops, the heart works harder to pump blood, and core temperature climbs faster.
The medications also interact with heat in less obvious ways. They can increase blood viscosity, making circulation less efficient. Some users report lower blood pressure on GLP-1s, which worsens heat intolerance since the body struggles to redirect blood to the skin for cooling.
Dr. recommendations for GLP-1 users in summer include deliberate hydration. Drink water regularly before thirst signals appear. Stay indoors during peak heat hours, typically 10 AM to 4 PM. Wear light, loose clothing and monitor for early warning signs like dizziness or unusual fatigue.